Reveal Pharma

Reveal is the future of medical imaging: + safer gadolinium-free contrast-enhanced MRI scans + precision imaging platform: empowering personalized medicine

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Founded July 2016
  • Employees 8
  • Incorporation Type C-corp
  • Website revealpharma.com

Company Summary

Reveal solves major challenges in medical imaging:
+ safer contrast-enhanced MRI imaging without gadolinium
+ precision imaging platform enabling personalized medicine & targeted therapeutics

Market:
General purpose MRI: 40 million scans per year, $2B market
Molecular imaging: will parallel growth in targeted therapeutics eg NASH

Technology:
Patented gadolinium-free MRI contrast agent RVP-001 invented at MGH
Stage: preparing for IND (Q1 '21)

Team

  • Vera Hoffman

  • Peter Caravan
    co-founder

    Associate Professor, Harvard Medical School / Massachusetts General Hospital
    Co-Director, Institute for Innovation in Imaging, Massachusetts General Hospital

  • Eric Gale
    co-founder

    Assistant Professor, Harvard Medical School / Massachusetts General Hospital

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free